Roxana Rustomjee

6.8k total citations · 1 hit paper
44 papers, 4.0k citations indexed

About

Roxana Rustomjee is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Roxana Rustomjee has authored 44 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 26 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Roxana Rustomjee's work include Tuberculosis Research and Epidemiology (33 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers) and Pneumonia and Respiratory Infections (10 papers). Roxana Rustomjee is often cited by papers focused on Tuberculosis Research and Epidemiology (33 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers) and Pneumonia and Respiratory Infections (10 papers). Roxana Rustomjee collaborates with scholars based in South Africa, United States and United Kingdom. Roxana Rustomjee's co-authors include Jenny Allen, Pamela Nabeta, David H. Persing, Mark D. Perkins, Eduardo Gotuzzo, Ana Milovic, Shubhada Shenai, Martin Jones, David Alland and Robert Blakemore and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Roxana Rustomjee

43 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

2010 1.6k citations Catharina Boehme, Pamela Nabeta et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxana Rustomjee South Africa	22	3.2k	2.5k	1.3k	594	247	44	4.0k
Payam Nahid United States	32	3.3k 1.0×	2.5k 1.0×	1.2k 0.9×	964 1.6×	348 1.4×	102	4.6k
Rosella Centis Italy	40	4.1k 1.3×	2.8k 1.1×	1.5k 1.1×	705 1.2×	225 0.9×	138	5.1k
Rodney Dawson South Africa	38	3.3k 1.0×	2.5k 1.0×	1.1k 0.8×	808 1.4×	259 1.0×	82	4.4k
Matthew Bates United Kingdom	34	2.9k 0.9×	2.5k 1.0×	986 0.7×	672 1.1×	206 0.8×	93	4.3k
Peter Mwaba Zambia	44	4.4k 1.4×	3.4k 1.3×	1.5k 1.1×	847 1.4×	338 1.4×	111	6.4k
Nesri Padayatchi South Africa	37	3.6k 1.1×	2.7k 1.1×	1.1k 0.8×	373 0.6×	151 0.6×	131	4.4k
Max Salfinger United States	38	4.3k 1.3×	4.1k 1.6×	1.8k 1.4×	723 1.2×	185 0.7×	113	5.7k
Reynaldo Dietze Brazil	40	2.9k 0.9×	2.9k 1.1×	806 0.6×	449 0.8×	470 1.9×	167	4.9k
Melvin Spigelman United States	24	2.6k 0.8×	1.8k 0.7×	788 0.6×	1.1k 1.9×	269 1.1×	43	3.8k
Neel R. Gandhi United States	35	5.5k 1.7×	4.4k 1.7×	2.0k 1.5×	696 1.2×	293 1.2×	125	6.7k

Countries citing papers authored by Roxana Rustomjee

Since Specialization

Citations

This map shows the geographic impact of Roxana Rustomjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Rustomjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Rustomjee more than expected).

Fields of papers citing papers by Roxana Rustomjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Rustomjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Rustomjee. The network helps show where Roxana Rustomjee may publish in the future.

Co-authorship network of co-authors of Roxana Rustomjee

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana Rustomjee. A scholar is included among the top collaborators of Roxana Rustomjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana Rustomjee. Roxana Rustomjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Denti, Paolo, Helen McIlleron, Peter J. Smith, et al.. (2024). Pharmacokinetics of ethambutol and weight banded dosing in South African adults newly diagnosed with tuberculosis and HIV. Antimicrobial Agents and Chemotherapy. 69(2). e0120024–e0120024.

Mthiyane, Thuli, James Millard, John Adamson, et al.. (2020). N -Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N -Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment. Antimicrobial Agents and Chemotherapy. 64(4). 16 indexed citations

Mthiyane, Thuli, Jonny Peter, Jenny Allen, et al.. (2019). Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously-ill HIV-infected patients with sputum smear-negative pulmonary tuberculosis. Journal of Thoracic Disease. 11(8). 3505–3514. 6 indexed citations

Andrews, Jason R., Mark Hatherill, Sabine Hermans, et al.. (2018). Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings. The Lancet Infectious Diseases. 19(3). e65–e76. 27 indexed citations

Mthiyane, Thuli, et al.. (2016). Longitudinal assessment of health related quality of life of HIV infected patients treated for tuberculosis and HIV in a high burden setting. Quality of Life Research. 25(12). 3067–3076. 7 indexed citations

Gandhi, Neel R., Thuli Mthiyane, Koleka Mlisana, et al.. (2015). Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa. PLoS ONE. 10(7). e0132076–e0132076. 11 indexed citations

Mthiyane, Thuli, Roxana Rustomjee, Alexander S. Pym, et al.. (2015). Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden. International Journal of Infectious Diseases. 36. 46–53. 1 indexed citations

Rustomjee, Roxana & Alimuddin Zumla. (2015). Delamanid expanded access novel treatment of drug resistant tuberculosis. Infection and Drug Resistance. 8. 359–359. 19 indexed citations

Merle, Corinne, Katherine Fielding, M. Gninafon, et al.. (2014). A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis. New England Journal of Medicine. 371(17). 1588–1598. 262 indexed citations

10.

Bantubani, Nonkqubela, Catherine Connolly, Roxana Rustomjee, et al.. (2014). High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission. PLoS ONE. 9(3). e90868–e90868. 32 indexed citations

11.

Rustomjee, Roxana, Stephen Lockhart, Jacqueline E. Shea, et al.. (2013). Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: A discussion of the adaptive licensure concept. Tuberculosis. 94(2). 178–182. 6 indexed citations

12.

Riou, Catherine, Blas Peixoto, Lindi Roberts, et al.. (2012). Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis. PLoS ONE. 7(5). e36886–e36886. 76 indexed citations

13.

Rustomjee, Roxana, Michael J. Brennan, Rima McLeod, et al.. (2012). Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents. Tuberculosis. 93(2). 136–142. 8 indexed citations

14.

Holtz, Timothy H., Thuli Mthiyane, Douglas S. Ross, et al.. (2011). Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. The Lancet Infectious Diseases. 11(7). 533–540. 38 indexed citations

15.

Boehme, Catharina, Pamela Nabeta, Doris Hillemann, et al.. (2010). Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. New England Journal of Medicine. 363(11). 1005–1015. 1639 indexed citations breakdown →

16.

Rustomjee, Roxana, et al.. (2009). Evaluation of directly observed therapy for tuberculosis in KwaZulu-Natal, South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 103(6). 571–574. 12 indexed citations

17.

Sirgel, F A, P. Bernard Fourie, Peter R. Donald, et al.. (2005). The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 172(1). 128–135. 83 indexed citations

18.

Rustomjee, Roxana. (2002). A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. Journal of Antimicrobial Chemotherapy. 49(5). 875–878. 31 indexed citations

19.

Rustomjee, Roxana, Quarraisha Abdool Karim, Salim S. Abdool Karim, Marie Laga, & Zena Stein. (1999). Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS. 13(12). 1511–1515. 44 indexed citations

20.

Rustomjee, Roxana & Salim S. Abdool Karim. (1997). Underreporting and overreporting of hepatitis B at a tertiary hospital. South African Medical Journal. 87(2). 249–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact